Literature DB >> 28936453

Shared decision making in the treatment of stage I non small cell lung cancer-a choice which should equally involve both sides.

Aurel Ottlakan1, Jozsef Furak1, Gaetano Rocco2.   

Abstract

Entities:  

Year:  2017        PMID： 28936453      PMCID： PMC5599279          DOI： 10.21037/atm.2017.06.03

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  20 in total

Review 1.  Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?

Authors:  René-Olivier Mirimanoff
Journal:  Chin Clin Oncol       Date:  2015-12

2.  Opinions of lung cancer clinicians on shared decision making in early-stage non-small-cell lung cancer.

Authors:  Sahar Mokhles; Alex P W M Maat; Joachim G J V Aerts; Joost J M E Nuyttens; Ad J J C Bogers; Johanna J M Takkenberg
Journal:  Interact Cardiovasc Thorac Surg       Date:  2017-08-01

3.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Authors:  Frank J Lagerwaard; Naomi E Verstegen; Cornelis J A Haasbeek; Ben J Slotman; Marinus A Paul; Egbert F Smit; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

4.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

Review 5.  SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

Authors:  Hanbo Chen; Alexander V Louie
Journal:  Curr Treat Options Oncol       Date:  2016-06

6.  Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.

Authors:  Anand Shah; Stephen M Hahn; Robert L Stetson; Joseph S Friedberg; Taine T V Pechet; David J Sher
Journal:  Cancer       Date:  2013-05-29       Impact factor: 6.860

7.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Authors:  Peter Goldstraw; Kari Chansky; John Crowley; Ramon Rami-Porta; Hisao Asamura; Wilfried E E Eberhardt; Andrew G Nicholson; Patti Groome; Alan Mitchell; Vanessa Bolejack
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

8.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial.

Authors:  Alexander V Louie; Erik van Werkhoven; Hanbo Chen; Egbert F Smit; Marinus A Paul; Joachim Widder; Harry J M Groen; Ben E E M van den Borne; Katrien De Jaeger; Ben J Slotman; Suresh Senan
Journal:  Radiother Oncol       Date:  2015-10       Impact factor: 6.280

Review 10.  Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.

Authors:  Han-Yu Deng; Yun-Cang Wang; Peng-Zhi Ni; Gang Li; Xiao-Yan Yang; Yi-Dan Lin; Lun-Xu Liu
Journal:  Eur J Cardiothorac Surg       Date:  2017-02-01       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.